论文部分内容阅读
目的 :探讨不同药物治疗方案对同一疾病的经济效果。方法 :选择 12 0例确诊为前列腺增生症 (BPH)的门诊患者 ,将其随机分为 4组 ,分别口服阿夫唑嗪 (桑塔 )、普适泰 (舍尼通 )、盐酸坦索罗辛 (哈乐 )、非那雄胺 (保列治 )治疗 ,运用药物经济学的费用 效果分析方法进行评价。结果 :4种方法的总有效率分别为 83% ,72 % ,90 %和 88%。结论 :坦索罗辛 (哈乐 )是治疗BPH的较佳方案。
Objective: To explore the economic effects of different drug treatment programs on the same disease. Methods: One hundred and twenty outpatients with benign prostatic hyperplasia (BPH) diagnosed as BPH were randomly divided into 4 groups: oral alfuzosin (Sita), PTS (senecton), tamsulosin hydrochloride Xin (Harmony), finasteride (Prostate) treatment, the use of cost-effectiveness analysis of drug economics methods for evaluation. Results: The total effective rates of the four methods were 83%, 72%, 90% and 88% respectively. Conclusion: Tamsulosin (Harmony) is the better treatment of BPH.